advertisement

Topcon

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (11)

Showing records 1 to 11

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
20503 Drug-induced ocular disorders
Li J; Tripathi RC; Tripathi BJ
Drug Safety 2008; 31: 127-141
20374 Modeling of corneal and retinal pharmacokinetics after periocular drug administration
Amrite AC; Edelhauser HF; Kompella UB
Investigative Ophthalmology and Visual Science 2008; 49: 320-332
20610 Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Delivery 2007; 14: 507-515
20731 Challenges and solutions in topical ocular drug-delivery systems
Ali M; Byrne ME
Expert Review of Clinical Pharmacology 2008; 1: 145-161
20845 Barriers to Glaucoma Drug Delivery
Ghate D; Edelhauser HF
Journal of Glaucoma 2008; 17: 147-156
20409 Effect of eye pigmentation on transscleral drug delivery
Cheruvu NP; Amrite AC; Kompella UB
Investigative Ophthalmology and Visual Science 2008; 49: 333-341
20730 Controlled release gelatin hydrogels and lyophilisates with potential application as ocular inserts
Natu MV; Sardinha JP; Correia IJ; Gil MH
Biomedical Materials 2007; 2: 241-249
20529 A history of the development of eye drops used to treat glaucoma
Komatsu Y
Yakushigaku Zasshi 2007; 42: 7-16
20490 Clinical significance of topical instillation technique in Japanese glaucoma patients
Ikeda H; Tsukamoto H; Sugimoto A; Sawa A; Crabtree BL; Byrd HJ; Murakami T; Mishima HK; Kihira K
Pharmazie 2008; 63: 81-85
20545 Ocular surface changes in primary open angle glaucoma with long term topical anti glaucoma medication
Kamath AP; Satyanarayana S; Rodrigues FEA
Medical Journal Armed Forces India 2007; 63: 341-345
20536 On the correct use of eye drops
Steiner M
Australian Prescriber 2008; 31: 16-17

Issue 10-1

Change Issue


advertisement

Oculus